EDAP TMS SA -ADR (EDAP)
US2683111072 - ADR
We assign a fundamental rating of 3 out of 10 to EDAP. EDAP was compared to 193 industry peers in the Health Care Equipment & Supplies industry. EDAP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, EDAP is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year EDAP has reported negative net income.
EDAP had a negative operating cash flow in the past year.
In multiple years EDAP reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: EDAP reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of EDAP (-23.13%) is comparable to the rest of the industry.
EDAP has a Return On Equity (-37.20%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -23.13% | ||
| ROE | -37.2% | ||
| ROIC | N/A |
ROA(3y)-8.37%
ROA(5y)-5.07%
ROE(3y)-13.3%
ROE(5y)-8.18%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
EDAP has a worse Gross Margin (40.40%) than 65.10% of its industry peers.
In the last couple of years the Gross Margin of EDAP has remained more or less at the same level.
EDAP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.4% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.89%
GM growth 5Y-1.32%
2. Health
2.1 Basic Checks
EDAP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EDAP has about the same amount of shares outstanding.
Compared to 5 years ago, EDAP has more shares outstanding
EDAP has a better debt/assets ratio than last year.
2.2 Solvency
A Debt/Equity ratio of 0.08 indicates that EDAP is not too dependend on debt financing.
EDAP has a Debt to Equity ratio (0.08) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACC7.37%
2.3 Liquidity
EDAP has a Current Ratio of 2.84. This indicates that EDAP is financially healthy and has no problem in meeting its short term obligations.
EDAP has a Current ratio of 2.84. This is comparable to the rest of the industry: EDAP outperforms 43.23% of its industry peers.
A Quick Ratio of 2.30 indicates that EDAP has no problem at all paying its short term obligations.
EDAP has a Quick ratio (2.30) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.84 | ||
| Quick Ratio | 2.3 |
3. Growth
3.1 Past
EDAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -683.78%.
EDAP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.65%.
EDAP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.05% yearly.
EPS 1Y (TTM)-683.78%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q0%
Revenue 1Y (TTM)9.65%
Revenue growth 3Y13.2%
Revenue growth 5Y9.05%
Revenue growth Q2Q24.76%
3.2 Future
Based on estimates for the next years, EDAP will show a very strong growth in Earnings Per Share. The EPS will grow by 21.89% on average per year.
Based on estimates for the next years, EDAP will show a very strong growth in Revenue. The Revenue will grow by 21.64% on average per year.
EPS Next Y37.38%
EPS Next 2Y23.3%
EPS Next 3Y20.75%
EPS Next 5Y21.89%
Revenue Next Year13.53%
Revenue Next 2Y13.56%
Revenue Next 3Y14.99%
Revenue Next 5Y21.64%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for EDAP. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EDAP. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
EDAP's earnings are expected to grow with 20.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.3%
EPS Next 3Y20.75%
5. Dividend
5.1 Amount
No dividends for EDAP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EDAP TMS SA -ADR
NASDAQ:EDAP (5/6/2024, 3:30:01 PM)
7.08
-0.06 (-0.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap262.69M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -23.13% | ||
| ROE | -37.2% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.4% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.84 | ||
| Quick Ratio | 2.3 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-683.78%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y37.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.65%
Revenue growth 3Y13.2%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y